[On the administration of vasodilator agents following pacemaker implantation].
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000139:chemically induced; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D010138:Pacemaker, Artificial; D011725:Pyridines / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D009539:Nicotinic Acids; D011725:Pyridines; D014665:Vasodilator Agents; D013806:Theophylline; D005996:Nitroglycerin
Zur Gabe von gefässerweiternden Pharmaka nach Schrittmacherimplantation.